CD44 and cancer: The knowledge obtained from this biogenesis study of miR-21 regulated by Nanog-DROSHA-p68 complexes may provide useful foundation for designing new drug target to downregulate miR-21 and increase tumor cell death and enhance chemosensitivity for the treatment of HA/CD44-mediated cancer.